1. Home
  2. RGEN vs CHE Comparison

RGEN vs CHE Comparison

Compare RGEN & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CHE
  • Stock Information
  • Founded
  • RGEN 1981
  • CHE 1970
  • Country
  • RGEN United States
  • CHE United States
  • Employees
  • RGEN N/A
  • CHE N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CHE Medical/Nursing Services
  • Sector
  • RGEN Health Care
  • CHE Health Care
  • Exchange
  • RGEN Nasdaq
  • CHE Nasdaq
  • Market Cap
  • RGEN 6.5B
  • CHE 8.0B
  • IPO Year
  • RGEN N/A
  • CHE N/A
  • Fundamental
  • Price
  • RGEN $119.39
  • CHE $457.60
  • Analyst Decision
  • RGEN Buy
  • CHE Strong Buy
  • Analyst Count
  • RGEN 10
  • CHE 4
  • Target Price
  • RGEN $163.78
  • CHE $578.50
  • AVG Volume (30 Days)
  • RGEN 718.1K
  • CHE 179.9K
  • Earning Date
  • RGEN 11-11-2025
  • CHE 10-28-2025
  • Dividend Yield
  • RGEN N/A
  • CHE 0.53%
  • EPS Growth
  • RGEN N/A
  • CHE N/A
  • EPS
  • RGEN N/A
  • CHE 19.48
  • Revenue
  • RGEN $673,956,000.00
  • CHE $2,511,915,000.00
  • Revenue This Year
  • RGEN $16.79
  • CHE $5.91
  • Revenue Next Year
  • RGEN $13.68
  • CHE $6.72
  • P/E Ratio
  • RGEN N/A
  • CHE $23.39
  • Revenue Growth
  • RGEN 8.73
  • CHE 7.55
  • 52 Week Low
  • RGEN $102.97
  • CHE $408.42
  • 52 Week High
  • RGEN $182.52
  • CHE $623.61
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 49.56
  • CHE 51.96
  • Support Level
  • RGEN $112.73
  • CHE $439.54
  • Resistance Level
  • RGEN $122.71
  • CHE $462.47
  • Average True Range (ATR)
  • RGEN 4.85
  • CHE 8.93
  • MACD
  • RGEN -0.27
  • CHE -0.46
  • Stochastic Oscillator
  • RGEN 53.02
  • CHE 51.09

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Share on Social Networks: